GTC
Ghost Tree Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-225,000
| Closed | -$3.66M | – | 51 |
|
|
2024
Q2 | $3.66M | Hold |
225,000
| – | – | 1.14% | 32 |
|
|
2024
Q1 | $4.16M | Buy |
225,000
+175,000
| +350% | +$3.24M | 1.15% | 24 |
|
|
2023
Q4 | $1.57M | Sell |
50,000
-30,000
| -38% | -$939K | 0.51% | 36 |
|
|
2023
Q3 | $1.67M | Buy |
+80,000
| New | +$1.67M | 0.55% | 40 |
|
|
2020
Q3 | – | Sell |
-165,000
| Closed | -$8M | – | 46 |
|
|
2020
Q2 | $8M | Buy |
+165,000
| New | +$8M | 2.11% | 17 |
|
|
2019
Q3 | – | Sell |
-750,000
| Closed | -$20M | – | 40 |
|
|
2019
Q2 | $20M | Sell |
750,000
-150,000
| -17% | -$4.01M | 4.16% | 6 |
|
|
2019
Q1 | $24.2M | Buy |
900,000
+775,000
| +620% | +$20.8M | 6.31% | 2 |
|
|
2018
Q4 | $2.02M | Sell |
125,000
-375,000
| -75% | -$6.06M | 0.73% | 28 |
|
|
2018
Q3 | $10.4M | Sell |
500,000
-35,000
| -7% | -$727K | 2.21% | 13 |
|
|
2018
Q2 | $8.17M | Buy |
535,000
+135,000
| +34% | +$2.06M | 2.4% | 14 |
|
|
2018
Q1 | $8.99M | Buy |
+400,000
| New | +$8.99M | 1.82% | 16 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 44 |
|
|
2017
Q3 | – | Sell |
-275,000
| Closed | -$7.67M | – | 53 |
|
|
2017
Q2 | $7.67M | Sell |
275,000
-75,000
| -21% | -$2.09M | 1.59% | 17 |
|
|
2017
Q1 | $12M | Buy |
350,000
+250,000
| +250% | +$8.6M | 2.24% | 8 |
|
|
2016
Q4 | $2.88M | Sell |
100,000
-100,000
| -50% | -$2.88M | 0.69% | 41 |
|
|
2016
Q3 | $6.36M | Buy |
+200,000
| New | +$6.36M | 1.03% | 23 |
|
|
2016
Q2 | – | Sell |
-75,000
| Closed | -$2.1M | – | 52 |
|
|
2016
Q1 | $2.1M | Sell |
75,000
-175,000
| -70% | -$4.89M | 1.19% | 20 |
|
|
2015
Q4 | $8.91M | Buy |
+250,000
| New | +$8.91M | 3.65% | 9 |
|
|
2015
Q2 | – | Sell |
-120,000
| Closed | -$3.91M | – | 68 |
|
|
2015
Q1 | $3.91M | Buy |
+120,000
| New | +$3.91M | 1.41% | 27 |
|